| Basics |
|
Vera Therapeutics, Inc.
|
| IPO Date: |
May 14, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.94B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.75 | 3.38%
|
| Avg Daily Range (30 D): |
$0.62 | 2.17%
|
| Avg Daily Range (90 D): |
$0.57 | 2.33%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
1.17M |
| Avg Daily Volume (90 D): |
1.26M |
| Trade Size |
| Avg Trade Size (Sh.): |
73 |
| Avg Trade Size (Sh.) (30 D): |
72 |
| Avg Trade Size (Sh.) (90 D): |
78 |
| Institutional Trades |
| Total Inst.Trades: |
1,725 |
| Avg Inst. Trade: |
$2.24M |
| Avg Inst. Trade (30 D): |
$2.41M |
| Avg Inst. Trade (90 D): |
$2.28M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.33M |
| Avg Closing Trade (30 D): |
$3.17M |
| Avg Closing Trade (90 D): |
$3.17M |
| Avg Closing Volume: |
116.31K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-3.58
|
$-1.2
|
$-.81
|
|
Diluted EPS
|
$-3.58
|
$-1.2
|
$-.81
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -218.28M
|
$ -76.53M
|
$ -51.69M
|
|
Operating Income / Loss
|
$ -236.05M
|
$ -80.14M
|
$ -57.19M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 24.04M
|
$ -5.97M
|
$ -37.56M
|
|
PE Ratio
|
|
|
|
|
|
|